GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
-$30.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1 +$9.88M
2 +$9.81M
3 +$7.52M
4
AKRO icon
Akero Therapeutics
AKRO
+$5.54M
5
JBIO
Jade Biosciences
JBIO
+$4.98M

Top Sells

1 +$10.9M
2 +$10.1M
3 +$9.98M
4
KALV icon
KalVista Pharmaceuticals
KALV
+$7.81M
5
ASND icon
Ascendis Pharma
ASND
+$7.79M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
1
Ionis Pharmaceuticals
IONS
$11.3B
$19.8M 12.84%
500,000
+250,000
RZLT icon
2
Rezolute
RZLT
$835M
$13.5M 8.8%
3,033,462
+2,200,420
AMLX icon
3
Amylyx Pharmaceuticals
AMLX
$1.51B
$12.8M 8.34%
2,000,000
+188,004
LEGN icon
4
Legend Biotech
LEGN
$5.88B
$12.4M 8.08%
350,000
+211,760
ABVX
5
Abivax
ABVX
$7.06B
$9.88M 6.42%
1,291,617
-346,494
NGNE icon
6
Neurogene
NGNE
$427M
$7.26M 4.72%
485,859
+14,895
AKBA icon
7
Akebia Therapeutics
AKBA
$803M
$7.23M 4.7%
1,985,915
-2,987,925
EOLS icon
8
Evolus
EOLS
$439M
$6.63M 4.31%
720,118
-224,625
ACLX icon
9
Arcellx
ACLX
$4.7B
$6.58M 4.28%
100,000
+55,000
XENE icon
10
Xenon Pharmaceuticals
XENE
$3.14B
$6.26M 4.07%
200,000
-45,272
AKRO icon
11
Akero Therapeutics
AKRO
$4.31B
$5.54M 3.6%
+103,848
JBIO
12
Jade Biosciences
JBIO
$460M
$4.98M 3.24%
+498,054
CYTK icon
13
Cytokinetics
CYTK
$6.92B
$4.96M 3.22%
150,000
-220,000
IMVT icon
14
Immunovant
IMVT
$3.3B
$4.19M 2.73%
262,176
-112,824
UNCY icon
15
Unicycive Therapeutics
UNCY
$90.6M
$3.8M 2.47%
796,558
-301,442
KALV icon
16
KalVista Pharmaceuticals
KALV
$562M
$3.65M 2.38%
323,170
-691,197
TSHA icon
17
Taysha Gene Therapies
TSHA
$1.3B
$3.46M 2.25%
+1,500,000
DBVT
18
DBV Technologies
DBVT
$422M
$3.43M 2.23%
+374,679
ZURA icon
19
Zura Bio
ZURA
$240M
$3.33M 2.16%
3,170,194
UPB
20
Upstream Bio Inc
UPB
$1.18B
$3.29M 2.14%
300,000
CNTX icon
21
Context Therapeutics
CNTX
$113M
$3.07M 2%
4,683,711
CNTA
22
Centessa Pharmaceuticals
CNTA
$3.24B
$2.96M 1.92%
225,000
+75,298
SRRK icon
23
Scholar Rock
SRRK
$2.85B
$2.18M 1.42%
+61,607
PMN icon
24
ProMIS Neurosciences
PMN
$23.2M
$1.28M 0.83%
2,645,128
PLRX icon
25
Pliant Therapeutics
PLRX
$111M
$986K 0.64%
850,000